Product Images Propafenone Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 13 images provide visual information about the product associated with Propafenone Hydrochloride NDC 51407-479 by Golden State Medical Supply, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

51407-477-60OL.jpg - 51407 477 60OL

51407-477-60OL.jpg - 51407 477 60OL

PROPAFENONE HYDROCHLORIDE is an extended-release capsule used for treating irregular heartbeats. The pack contains 60 capsules of 225 mg of the medicine. Dosage information is available in the package insert. It is advised to store capsules in a cool and dry place and dispense only with patient instructions. The provided website can be visited to print patient information.*

51407-478-60OL.jpg - 51407 478 60OL

51407-478-60OL.jpg - 51407 478 60OL

51407-479-60OL.jpg - 51407 479 60OL

51407-479-60OL.jpg - 51407 479 60OL

This is a description of a drug product with NDC 51407-479-60 and the name Propafenone Hydrochloride. It comes in extended-release capsules with a potency of 425 mg and is typically packaged in quantities of 60 capsules. The package insert contains information about dosage. The pharmacist is advised to dispense patient information with each patient. The product must be stored at 20°C (68-77°F) and at USP-controlled room temperature. The text contains errors and is difficult to read, therefore some information may be incorrect.*

image description - fig1

image description - fig1

image description - fig10

image description - fig10

image description - fig11

image description - fig11

image description - fig2

image description - fig2

This appears to be a graph or chart displaying the proportion of patients without an event over a certain number of days for two different treatments: Propafenone ER 425 mg bid and a placebo. The text also mentions a patient crossover on Day 273 and an event occurring on Day 291 for one group. More information or context is needed to fully understand the data being presented.*

image description - fig6

image description - fig6

image description - fig7

image description - fig7

image description - fig8

image description - fig8

image description - fig9

image description - fig9

image description - logo

image description - logo

second logo.jpg - second logo

second logo.jpg - second logo

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.